Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

Women with PCOS often have depression and anxiety, so they should be checked for these issues.

The link between anabolic agents and colorectal cancer risk is unclear.

Female pattern hair loss has multiple causes and treatments, with new therapies showing promise.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

Testosterone therapy is effective and safe for women with low sexual desire, but it's hard to access.

The trial aims to test if spironolactone is an effective acne treatment for women without the side effects of current treatments.

The guideline refines PCOS diagnosis, promotes a healthy lifestyle, reviews treatments, and stresses long-term follow-up.

Adult female acne is complex and requires a combination of treatments for effective management.

Women with PCOS have a higher risk of heart disease.

Testosterone therapy for postmenopausal women appears safe and may protect against heart disease, but requires constant monitoring and more research for long-term effects.

Medications for glucose metabolism and weight control, combined therapy options, and herbal medicines may help regulate menstrual cycle in adolescents with PCOS.

Polycystic ovary syndrome and iron overload share similar symptoms and can be potentially treated with blood removal, diet changes, and probiotics.

Cannabidiol shows promise as an effective treatment for acne.

Hormone therapy improves mental well-being in transgender individuals but requires ongoing health monitoring.

Oxidative stress and immune dysfunction are linked to both Hashimoto's thyroiditis and polycystic ovary syndrome, with diet and specific treatments important for managing these conditions.

Preventing cancer involves lifestyle changes, vaccinations, early screening, and understanding cancer's molecular basis.

The document concluded that more research is needed to understand how estrogen affects the enzyme involved in hirsutism development.

PCOS causes sexual dysfunction, needing comprehensive treatment.

A new method effectively predicts estrogen-related health effects for early screening.

PCOS may be linked to spina bifida in young females.

CXXC5 can both suppress and promote cancer, making it a complex target for treatment.

Early detection, consistent management, and lifestyle changes are crucial for managing HAIR-AN syndrome effectively.

Most patients with PCOS were prescribed medroxyprogesterone acetate or oral contraceptives, with some experiencing side effects or needing prescription changes.

Balanced hormones are crucial for women's health, and can be managed with lifestyle changes or hormone therapy if needed.

Choosing the right starting dose of Clomiphene Citrate for ovulation induction in PCOS women is challenging; higher BMI and hormone levels may indicate resistance to the standard dose.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

PCOS is managed by lifestyle changes and personalized medication to improve symptoms and fertility.

Biomaterials can improve non-viral gene delivery by enhancing DNA uptake and reducing toxicity.

Ovarian and stress hormones can change GABA A receptors through neurosteroids.